Search Results

There are 75944 results for: content related to: PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus–related systemic vasculitis

  1. You have free access to this content
    Hepatitis C virus: How genetic variability affects pathobiology of disease

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue s1, January 2011, Pages: 83–95, Kazuaki Chayama and C Nelson Hayes

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1440-1746.2010.06550.x

  2. You have free access to this content
    Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus–related vasculitis: A long-term followup study of thirty-two patients

    Arthritis & Rheumatism

    Volume 60, Issue 8, August 2009, Pages: 2531–2540, Benjamin Terrier, David Saadoun, Damien Sène, Jérémie Sellam, Laurent Pérard, Brigitte Coppéré, Alexandre Karras, François Blanc, Matthias Buchler, Emmanuelle Plaisier, Pascale Ghillani, Michelle Rosenzwajg and Patrice Cacoub

    Version of Record online : 30 JUL 2009, DOI: 10.1002/art.24703

  3. You have free access to this content
    Antiviral therapy for hepatitis C virus–associated mixed cryoglobulinemia vasculitis: A long-term followup study

    Arthritis & Rheumatism

    Volume 54, Issue 11, November 2006, Pages: 3696–3706, David Saadoun, Mathieu Resche-Rigon, Vincent Thibault, Jean-Charles Piette and Patrice Cacoub

    Version of Record online : 30 OCT 2006, DOI: 10.1002/art.22168

  4. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  5. Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin

    Journal of Viral Hepatitis

    Volume 19, Issue 4, April 2012, Pages: 263–270, D. A. Kelly, B. Haber, R. P. González-Peralta, K. F. Murray, M. M. Jonas, J. P. Molleston, M. R. Narkewicz, F. R. Sinatra, T. Lang, A. Lachaux, S. Wirth, M. Shelton, H. S. Te, H. Pollack, W. Deng, S. Noviello and J. K. Albrecht

    Version of Record online : 17 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01544.x

  6. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  7. Peginterferon alfa-2a versus Peginterferon alfa-2b as Initial Treatment of Hepatitis C Virus Infection: A Cost-Utility Analysis from the Perspective of the Veterans Affairs Health Care System

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 6, June 2007, Pages: 813–824, Wei-Shi Yeh, Edward P. Armstrong, Grant H. Skrepnek and Daniel C. Malone

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.6.813

  8. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  9. You have free access to this content
    Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 5, March 2008, Pages: 433–440, V. K. RUSTGI, S. ESPOSITO, F. M. HAMZEH and M. L. SHIFFMAN

    Version of Record online : 10 DEC 2007, DOI: 10.1111/j.1365-2036.2007.03587.x

  10. You have free access to this content
    A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 5, March 2003, Pages: 687–694, M. Buti, M. Medina, M. A. Casado, J. B. Wong, L. Fosbrook and R. Esteban

    Version of Record online : 28 FEB 2003, DOI: 10.1046/j.1365-2036.2003.01453.x

  11. You have free access to this content
    AASLD Abstract (pp. 162A–266A)

    Hepatology

    Volume 40, Issue S4, October 2004, Pages: 267A–369A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840400504

  12. Follow-up of Adverse Drug Reactions from Peginterferon alfa-2b—Ribavirin Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 11, November 2004, Pages: 1546–1553, Dr. Haleh Bagheri, Dr. Atoussa Fouladi, Dr. Karl Barange, Dr. Maryse Lapeyre-Mestre, Dr. Jean-Louis Payen, Dr. Jean Louis Montastruc and Dr. Jean-Pierre Vinel

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.16.1546.50947

  13. You have free access to this content
    Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin

    Hepatology

    Volume 35, Issue 4, April 2002, Pages: 930–936, Maria Buti, Francisco Sanchez-Avila, Yoav Lurie, Carlos Stalgis, Auristela Valdés, Maria Martell and Rafael Esteban

    Version of Record online : 30 DEC 2003, DOI: 10.1053/jhep.2002.32150

  14. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  15. Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: e81–e90, S. Mauss, D. Hueppe, C. John, J Goelz, R. Heyne, B. Moeller, R. Link, G. Teuber, A. Herrmann, M. Spelter, S. Wollschlaeger, A. Baumgarten, K.-G. Simon, N. Dikopoulos and T. Witthoeft

    Version of Record online : 16 SEP 2010, DOI: 10.1111/j.1365-2893.2010.01372.x

  16. Current Therapies for Chronic Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 1, January 2011, Pages: 92–111, McKenzie C. Ferguson

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.1.92

  17. You have free access to this content
    RESEARCH POSTER ABSTRACTS

    Value in Health

    Volume 13, Issue 7, November 2010, Pages: A250–A480,

    Version of Record online : 11 OCT 2010, DOI: 10.1111/j.1524-4733.2010.00791_2.x

  18. You have free access to this content
    Interferons in the treatment of multiple myeloma

    Cancer

    Volume 59, Issue S3, 1 February 1987, Pages: 594–600, M. Robert Cooper and Charles E. Welander

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19870201)59:3+<594::AID-CNCR2820591303>3.0.CO;2-7

  19. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  20. Boceprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 2, February 2012, Pages: 173–190, Olga M. Klibanov, Stephen B. Vickery, Jacqueline L. Olin, Lisa S. Smith and Shannon H. Williams

    Version of Record online : 30 JAN 2012, DOI: 10.1002/PHAR.1046